Infertility Market Share

ID: MRFR/LS/4687-HCR

100 Pages

Rahul Gotadki

October 2025

Infertility Market Research Report By Treatment Type (Assisted Reproductive Technology, Hormone Therapy, Surgery, Fertility Preservation), By End User (Hospitals, Fertility Clinics, Home Care Settings), By Gender (Female, Male), By Cause of Infertility (Ovulatory Disorders, Uterine or Cervical Abnormalities, Tubal Factors, Male Factor Infertility) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Share

Infertility Market Share Analysis

The Infertility Market is witnessing dynamic strategies for market share positioning as it addresses a crucial element of reproductive health. With an emphasis on offering solutions to couples having trouble conceiving, businesses in this industry deliberately navigate the competitive landscape to increase their market position. Businesses are aggressively entering new international markets. This entails setting up fertility facilities, forming alliances with medical professionals, and guaranteeing that infertility treatments are accessible in various areas. The different needs of couples looking for reproductive treatments around the world are met by global expansion. Businesses are concentrating on tailored medicine since they understand how different every infertility issue is. More efficient and patient-centered reproductive treatments are made possible by customized treatment programs based on genetic variables, lifestyle factors, and unique patient profiles. Innovation is essential, especially when it comes to preserving fertility. Businesses are spending money on research to advance sperm and egg-freezing technology, giving people the choice to freeze their fertility for future family planning. Businesses are funding patient and healthcare professional education programs. Raising knowledge about the reasons for infertility, accessible therapies, and the emotional aspects of fertility journeys is facilitated by educational campaigns, counseling services, and training programs. Embracing the digital transformation, companies are integrating fertility services with telehealth options. Remote consultations, virtual monitoring, and telemedicine platforms increase accessibility and convenience in fertility care, especially for patients in remote areas. Companies are incorporating sustainability features into their infertility treatment programs. This includes eco-friendly clinic practices, responsible waste management, and efforts to reduce the environmental impact of fertility treatment procedures. Companies that recognize the impact of male factors in infertility are creating solutions that center on the reproductive health of men. This covers developments in male fertility therapies, sperm analysis, and the treatment of disorders that impact male fertility. Innovations in reproductive health are the subject of ongoing research. Businesses are spending money on research to investigate cutting-edge technology like artificial intelligence for predicting fertility, improvements in embryo selection, and creative methods to increase the success rates of infertility treatments. Businesses are looking into integrating their services with genetic counseling. Giving couples undergoing assisted reproductive procedures thorough genetic information on potential dangers and conditions related to fertility treatments helps them make educated decisions.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected growth of the Infertility market?

The Infertility market is the expected increase in total market value of 7.67 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Infertility market?

Infertility market size was valued at approximately 2.04 billion USD in 2024. This figure will reach 7.67 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Infertility market?

Infertility market is expected to grow at a CAGR of 12.82% between 2025 and 2035.

How much will the Infertility market be worth by 2035?

Infertility market is expected to be worth of 7.67 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Infertility market perform over the next 10 years?

Over the next 10 years the Infertility market is expected to shift from usd billion 2.04 to 7.67 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

What is the expected market valuation for the Global Infertility Market by 2035?

By 2035, the Global Infertility Market is anticipated to reach a valuation of 30.5 USD Billion.

Which region is expected to have the largest market share in the Global Infertility Market in 2024?

North America is anticipated to hold the largest market share, valued at 7.52 USD Billion in 2024.

What will be the market size for Assisted Reproductive Technology by 2035?

The market size for Assisted Reproductive Technology is expected to reach 12.8 USD Billion by 2035.

Which key players are involved in the Global Infertility Market?

Major players include Ferring Pharmaceuticals, Boston IVF, OvaScience, and Thermo Fisher Scientific.

How is the European market for infertility expected to evolve by 2035?

The European market for infertility is projected to grow to 8.0 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per Market Research Future analysis, the Infertility Market was valued at 2.04 USD Billion in 2024 and is projected to grow to 7.67 USD Billion by 2035, with a CAGR of 12.82% from 2025 to 2035. The market is driven by increasing awareness of infertility treatments, technological advancements, and rising lifestyle-related disorders affecting fertility.

Key Market Trends & Highlights

The Global Infertility Market is influenced by several key trends.

Assisted Reproductive Technology is expected to reach 7.67 USD Billion by 2035. Hormone Therapy is projected to grow to 6.0 USD Billion by 2035. Fertility Clinics are becoming critical players in providing personalized services. Telemedicine is transforming patient access to fertility specialists.

Market Size & Forecast

2024 Market Size	USD 2.04 Billion
2035 Market Size	USD 7.67 Billion
CAGR (2025-2035)	12.82%
Largest Regional Market Share in 2024	North America.

Major Players

Key players include Ferring Pharmaceuticals, Boston IVF, OvaScience, Thermo Fisher Scientific, and Merck KGaA.

Market Trends

The Global Infertility Market is currently being impacted by a number of significant market trends that are driven by the evolution of societal norms and the advancement of medical technology. As a result of the increasing prevalence of infertility and the growing awareness of reproductive health issues, a greater number of couples are increasingly seeking fertility treatments.

Infertility Market Market Drivers

Market Growth Projections

The Global Infertility Market Industry is projected to experience substantial growth in the coming years. By 2024, the market is anticipated to reach 19.7 USD Billion, with further expansion expected to 30.5 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 4.03% from 2025 to 2035. Such projections highlight the increasing demand for infertility treatments and services, driven by factors such as rising infertility rates, technological advancements, and greater awareness. As the market evolves, stakeholders are likely to explore new opportunities for innovation and investment, positioning themselves to meet the needs of a growing patient population.

Rising Prevalence of Infertility

The Global Infertility Market Industry is witnessing a notable increase in infertility rates, attributed to various factors such as delayed childbearing and lifestyle changes. According to recent data, approximately 15% of couples globally experience infertility issues. This rising prevalence is driving demand for fertility treatments and services, contributing to the market's projected growth. By 2024, the market is expected to reach 19.7 USD Billion, reflecting a growing awareness and acceptance of assisted reproductive technologies. As more individuals seek solutions for infertility, the industry is likely to expand, fostering innovation in treatment options and enhancing patient access.

Government Initiatives and Support

Government policies and initiatives play a crucial role in shaping the Global Infertility Market Industry. Many countries are implementing programs to support infertility treatments, including funding for research and subsidies for patients. For example, some nations offer financial assistance for IVF procedures, making them more accessible to a broader population. These initiatives not only alleviate the financial burden on couples but also encourage the development of advanced fertility clinics and services. As governments recognize the importance of addressing infertility, the market is likely to benefit from increased investment and support, further driving growth in the coming years.

Demographic Shifts and Lifestyle Changes

Demographic changes, including an aging population and evolving lifestyle choices, are significantly impacting the Global Infertility Market Industry. As individuals prioritize education and career advancement, many are delaying family planning, which can lead to increased infertility rates. Additionally, lifestyle factors such as obesity, smoking, and stress are contributing to fertility challenges. These shifts necessitate a greater demand for fertility solutions, as couples seek to overcome the biological limitations associated with age and lifestyle. The market's growth is expected to reflect these demographic trends, with a notable increase in service utilization as awareness of fertility issues rises.

Technological Advancements in Fertility Treatments

Innovations in reproductive technologies are significantly influencing the Global Infertility Market Industry. Techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT) are becoming increasingly sophisticated. These advancements not only improve success rates but also enhance patient experiences. For instance, the introduction of artificial intelligence in embryo selection has shown promising results in optimizing outcomes. As these technologies evolve, they are expected to attract more patients, thereby propelling the market forward. The anticipated growth trajectory suggests that by 2035, the market could reach 30.5 USD Billion, underscoring the importance of continuous innovation.

Increasing Awareness and Acceptance of Fertility Treatments

The Global Infertility Market Industry is experiencing a shift in societal attitudes towards fertility treatments. Increased awareness campaigns and educational initiatives are helping to destigmatize infertility and promote available treatment options. As a result, more individuals and couples are seeking assistance, leading to a rise in demand for fertility services. This trend is particularly evident in urban areas where access to information is more prevalent. The growing acceptance of assisted reproductive technologies is expected to contribute to a compound annual growth rate (CAGR) of 4.03% from 2025 to 2035, indicating a robust market expansion driven by informed consumer choices.

Market Segment Insights

Infertility Market Treatment Type Insights

The Global Infertility Market, particularly in the Treatment Type segment, showcases a diverse range of avenues catering to individuals facing fertility challenges. By 2024, the market is expected to see significant valuation, driven by escalating demand for innovative and effective treatments. One crucial area, Assisted Reproductive Technology, holds a dominant position, anticipated to reach a valuation of 8.5 USD Billion in 2024 and projected to grow to 12.8 USD Billion by 2035.

This segment reflects its importance as a primary method for couples struggling with infertility, providing options like in vitro fertilization (IVF) that have a marked success rate. Hormone Therapy, another vital category within this market, is valued at approximately 4.0 USD Billion in 2024, with expectations of reaching 6.0 USD Billion in 2035. This treatment remains significant due to its role in regulating hormonal levels, thereby enhancing fertility potential.

Surgery, capturing a valuation of 3.5 USD Billion in 2024 and expected to grow to 5.3 USD Billion by 2035, also plays a critical role, particularly in addressing physical obstructions or abnormalities that affect fertility. Furthermore, Fertility Preservation, valued at 3.74 USD Billion in 2024 and projected to reach 6.4 USD Billion in 2035, caters to individuals looking to safeguard their fertility for the future, often crucial for those considering delayed parenthood.Such growth trends in these treatment types underline the rising recognition of infertility as a serious health concern, driving both demand and innovation.

Infertility Market End User Insights

The Global Infertility Market revenue is significantly influenced by the End User segment, encompassing various healthcare settings that provide infertility treatments and related services. By 2024, the market is expected to be valued at 19.74 billion USD, reflecting a growing emphasis on the need for effective reproductive health solutions globally.

Hospitals typically represent a considerable part of the Global Infertility Market segmentation, offering comprehensive care, advanced technology, and accessibility to specialists, which is vital for complex infertility cases.Fertility Clinics play an essential role in providing personalized services and innovative treatments tailored for couples facing fertility challenges, making them a critical player in the overall market dynamics. Home Care Settings are increasingly important as they offer convenience and a more comfortable environment for patients undergoing treatments, reflecting a trend toward more patient-centric care options.

Overall, the market growth opportunities within these environments are supported by rising infertility awareness and increasing acceptance of assisted reproductive technologies worldwide, bolstering the Global Infertility Market industry and driving improvements in reproductive health outcomes.The evolving landscape highlights the importance of tailored care, underscoring the diverse needs within the Global Infertility Market data and enhancing patient experience.

Infertility Market Gender Insights

The Global Infertility Market is poised for significant growth, with a projected value of 19.74 billion USD in 2024 and reaching 30.5 billion USD by 2035. This market segmentation by Gender plays a crucial role in understanding the dynamics of infertility treatment across different demographics. The Female segment remains an essential focus due to various factors such as age-related fertility decline and increasing demand for assisted reproductive technologies.

Meanwhile, the Male segment has also gained attention as male infertility contributes substantially to overall fertility challenges.In recent years, there has been growing awareness of male reproductive health issues, which is driving the need for innovative solutions. Additionally, the increased prevalence of lifestyle-related health issues, such as obesity and stress, impacts both genders and contributes to the demand for infertility treatments.

The continuous advancements in Research and Development and the rise in support networks for couples facing infertility are further propelling the Global Infertility Market growth. Understanding this segmentation is vital, as both Female and Male segments are significant for shaping treatment strategies and addressing the personal and emotional aspects of infertility globally.

Infertility Market Cause of Infertility Market Insights

The Global Infertility Market revenue is significantly driven by the various causes of infertility, encompassing key areas such as Ovulatory Disorders, Uterine or Cervical Abnormalities, Tubal Factors, and Male Factor Infertility Market. As of 2024, the overall market is projected to reach a valuation of 19.74 billion USD, with an expected consistent growth trajectory towards 2035. Ovulatory Disorders frequently represent a substantial contributor to infertility, emphasizing the importance of effective diagnosis and treatment options.

Meanwhile, Uterine or Cervical Abnormalities play a critical role in hindering conception, thereby further complicating fertility issues.Tubal Factors also significantly impact fertility rates, with blockages and damage to the fallopian tubes often necessitating advanced medical interventions. Male Factor Infertility Market is increasingly recognized as a dominant issue affecting couples; research indicates that this factor is essential for overall fertility assessments and treatments.

The challenges in addressing these various infertility causes are met with evolving opportunities in the Global Infertility Market industry, driven by research and development efforts targeting more effective therapies and patient management strategies.

Get more detailed insights about Infertility Market Research Report – Forecast to 2035

Regional Insights

The Global Infertility Market demonstrates significant growth, with a comprehensive valuation reaching 19.74 USD Billion in 2024. Regionally, North America holds a majority share, valued at 7.52 USD Billion in 2024 and poised to grow to 11.2 USD Billion by 2035, reflecting substantial investment in reproductive health technologies and increasing awareness of infertility treatments.

Europe follows, with a valuation of 5.3 USD Billion in 2024, showcasing a well-established health infrastructure and favorable policies supporting infertility treatments, expected to reach 8.0 USD Billion by 2035.The Asia-Pacific (APAC) region, with a valuation of 4.3 USD Billion in 2024, is witnessing rapid urbanization and a rise in disposable income, which are driving factors for market growth, projected to increase to 6.7 USD Billion by 2035.

South America, though smaller, still contributes with a valuation of 1.4 USD Billion in 2024, as cultural shifts are beginning to increase the demand for infertility solutions, projected to reach 2.2 USD Billion by 2035. The Middle East and Africa (MEA) is also on the rise, valued at 1.22 USD Billion in 2024, reflecting potential due to improving healthcare access, expected to grow to 2.4 USD Billion by 2035.These regional dynamics underline the diverse landscape of the Global Infertility Market, driven by unique cultural, economic, and healthcare factors.

Infertility Market Region

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

The Global Infertility Market has become a dynamic sector, driven by the increasing prevalence of infertility and the rising awareness of assisted reproductive technologies. Various factors, such as delayed marriages, lifestyle changes, and environmental influences, have contributed to the growing demand for infertility treatments across the globe.

As a result, numerous companies are vying for market share, offering a range of services from IVF procedures to hormone drugs and reproductive health services. Key players in the market are continually innovating and expanding their product offerings to meet the diverse needs of patients, making it increasingly competitive.

The market landscape is characterized by strategic partnerships, mergers, and acquisitions as companies seek to consolidate their positions and leverage complementary strengths in their pursuit of advancements in reproductive health.Ferring Pharmaceuticals has established a significant presence in the Global Infertility Market, recognized for its focus on reproductive medicine and women's health.

The company is well-known for its dedication to innovation and research, continually investing in the development of cutting-edge fertility treatments designed to improve success rates for couples facing infertility challenges. Ferring Pharmaceuticals excels in delivering high-quality products and personalized services that cater to the varying needs of patients, further strengthening its market position. Their robust portfolio includes a range of hormone treatments that are pivotal in fertility protocols.

By maintaining an emphasis on scientific excellence and patient-centered approaches, Ferring Pharmaceuticals has managed to carve out a strong foothold in this competitive arena, fostering relationships with healthcare providers to support patient journeys through infertility treatment.Boston IVF has positioned itself firmly within the Global Infertility Market, known for its comprehensive services that encompass all facets of reproductive health.

The company offers a wide array of treatments, including IVF, egg freezing, and fertility preservation, supported by a commitment to utilizing advanced technologies and innovative techniques. Boston IVF focuses on personalized patient care, enhancing the overall experience for individuals seeking fertility solutions. The company’s strategic growth includes partnerships with various healthcare entities and participation in clinical trials to advance reproductive health knowledge and technology.

Furthermore, Boston IVF continues to expand its geographical footprint through strategic mergers and acquisitions aimed at enhancing accessibility to its wide range of services. The dedication of Boston IVF to delivering quality and excellence in patient outcomes underlines its strengths within the competitive landscape of the Global Infertility Market, showcasing its leadership and commitment to excellence in reproductive healthcare.

Key Companies in the Infertility Market market include

Industry Developments

The Global Infertility Market has seen notable developments recently, driven by advancements in reproductive technologies and increased awareness surrounding infertility issues. Companies such as Ferring Pharmaceuticals, Boston IVF, and Merck KGaA have been actively involved in launching innovative fertility treatments.

For instance, in July 2023, Ferring Pharmaceuticals introduced a new product aimed at enhancing fertility efficiency, which is anticipated to improve patient outcomes. Significant mergers and acquisitions also characterize the market; Cook Medical acquired MediCorp in August 2023, aiming to expand its portfolio in reproductive health technologies, with major implications for collaboration and innovation in the sector. Furthermore, the valuation of companies like IVF Technologies and Vitrolife has surged due to rising demand for assisted reproductive technologies, reflecting a broader trend of increasing allocations towards Research and Development in this area.

Over the last couple of years, a substantial shift towards telemedicine in fertility consultations has transformed patient access and care, indicating evolving consumer preferences in the Global Infertility Market landscape. As awareness grows and technology advances, the market is poised for sustained growth in the upcoming years.

Future Outlook

Infertility Market Future Outlook

The Global Infertility Market is projected to grow at a 4.03% CAGR from 2025 to 2035, driven by advancements in reproductive technologies, increasing awareness, and rising infertility rates.

New opportunities lie in:

Develop innovative fertility preservation solutions targeting younger demographics. Expand telehealth services for remote fertility consultations and treatments. Invest in AI-driven diagnostics to enhance personalized treatment plans.

By 2035, the Global Infertility Market is expected to exhibit robust growth, reflecting evolving consumer needs and technological advancements.

Market Segmentation

Infertility Market Gender Outlook

Female
Male

Infertility Market End User Outlook

Hospitals
Fertility Clinics
Home Care Settings

Infertility Market Treatment Type Outlook

Assisted Reproductive Technology
Hormone Therapy
Surgery
Fertility Preservation

Infertility Market Cause of Infertility Outlook

Ovulatory Disorders
Uterine or Cervical Abnormalities
Tubal Factors
Male Factor Infertility Market

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	18.97(USD Billion)
MARKET SIZE 2024	19.74(USD Billion)
MARKET SIZE 2035	7.67 (USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	12.82% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Ferring Pharmaceuticals, Boston IVF, OvaScience, Thermo Fisher Scientific, Cook Medical, IVF Technologies, CryoBank, Merck KGaA, MediCorp, Vitrolife, Genea Limited, CooperSurgical, ReproTech, Irvine Scientific, Eugin Group
SEGMENTS COVERED	Treatment Type, End User, Gender, Cause of Infertility, Regional
KEY MARKET OPPORTUNITIES	Increased awareness and education, Advancements in reproductive technologies, Rising demand for IVF services, Growing investment in fertility clinics, Expansion of fertility preservation services
KEY MARKET DYNAMICS	Rising infertility rates, Advancements in reproductive technology, Increasing public awareness, Government funding and support, Growing trend of delayed parenthood
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA
Market Size 2024	2.04
Market Size 2025	2.30
Market Size 2035	7.67
Base Year	2024
Market Forecast Period	2025 - 2035